DOW JONES25,409.36-357.28 -1.39%
S&P 5002,954.22-24.54 -0.82%
NASDAQ8,567.37+0.89 0.01%

Cantor Fitzgerald Reiterates Neutral on Biogen, Raises Price Target to $361

Cantor Fitzgerald analyst Alethia Young reiterates Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $315 to $361.

Benzinga · 02/06/2020 12:38

Cantor Fitzgerald analyst Alethia Young reiterates Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $315 to $361.